Skip to main content
. Author manuscript; available in PMC: 2010 May 4.
Published in final edited form as: Epidemics. 2009 Mar 1;1(1):47–57. doi: 10.1016/j.epidem.2008.10.002

Table A1.

Self-reported recent injecting risk behaviors in young IDU in San Francisco, 2000–2001.

High-risk IDU (n=360) Medium-risk IDU (n=162) Low-risk IDU (n=322)

Median number of days injected, prior 30 (inter-quartile range) 25 (14–30) 20 (9–30) 20 (8–30)

Median typical number of injections per day injecting, prior 30 days (inter-quartile range) 3 (2–4) 2.5 (2–4) 2.5 (1.5–4)

Median # of injecting events, prior 30 days (number of days injected times usual number of injections per day injecting) (inter-quartile range) 69 (30–105) 45 (16–40) 42 (15–90)

Frequency of RNS* (prior 3 months)
 Always 5% --- ---
 Usually 7% --- ---
 Sometimes 22% --- ---
 Rarely 66% --- ---
 Never 0% 100% 100%

Median imputed number RNS* events, prior 30 days (inter-quartile range)*** 9 (4–15) 0 0

Median number of persons with whom engaged in RNS, prior 3 onths (inter-quartile range) 1 (1–2) 0 0

Frequency of AES** (prior 3 months)
 Always 18% 22% ---
 Usually 17% 19% ---
 Sometimes 27% 60% ---
 Rarely 21% --- 28%
 Never 17% --- 72%

Median imputed number of AES** events, prior 30 days (inter-quartile range)*** 12 (3–38) 17 (6–34) 0 (0–.7)

Median number of partners with whom pooled money to buy drugs, prior 3 months (inter-quartile range)**** 3 (1–4) 2 (1–5) 2 (0–4)
*

RNS, receptive needle sharing

**

AES, ancillary equipment sharing

***

Imputations multiplied the total number of injections per month by the proportion of injecting events in which risk behavior occurred in the prior 3 months, where Always=1; Usually=.75, Sometimes=.25, Rarely=.1, Never=0

****

This variable is used as a proxy for number of persons with whom the IDU engaged in AES